1. Maksimenko, A. V. (2012) Cardiological biopharmaceutics in concept of targeted drug transport: practical results and research perspectives, Acta Naturae, 4, 76–86.
2. Batool, S., Ferdous, S., Kamal, M. A., Iftikhar, H., and Rashid, S. (2013) In silico screening for identification of novel Aurora kinase inhibitors by molecular docking, dynamics simulations and ligand-based hypothesis approaches, Enz. Eng., 2, 1.
3. Wu, Z. L. (2012) Time for molecular glycobiology, J. Glycobiol., 1, e106.
4. Maksimenko, A. V., and Turashev, A. D. (2012) No-reflow phenomenon and endothelial glycocalyx of microcirculation, Biochem. Res. Int., 2012, 859231; DOI: 10.1155/2012/859231.
5. Reitsma, S., Slaaf, D. W., Vink, H., van Zandvoort, M. A., and oude Egbrink, M. G. A. (2007) The endothelial glycocalyx: compositions, functions, and visualization, Pflugers Arch., 454, 345–359.